Why the study?
Does antegrade, warm, blood, low-volume, single-dose cardioplegia improve hospital outcomes compared to pharmaco-cold crystalloid cardioplegia with HTK solution in patients undergoing primary CABG?
Does antegrade, warm, blood, low-volume, single-dose cardioplegia improve hospital outcomes compared to pharmaco-cold crystalloid cardioplegia with HTK solution in patients undergoing primary CABG?
Answers are grounded in this paper and cite their sources.
Equivalent hospital outcomes support safe use of single-dose warm blood cardioplegia in CABG; leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Базылев et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: